Syndicated Content about Biotechnology, Pharmaceutical and Healthcare

04:24 EDT 27th May 2016 | BioPortfolio

Latest global life science, pharmaceutical and healthcare news syndicated from over 50 publishers. 

Showing News Articles 1–25 of 280,000+

Friday 27th May 2016

OrbusNeich Launches Two Peripheral Artery Disease Devices

OrbusNeich, a vascular device company headquartered in Hong Kong, announced two new products to treat peripheral artery disease. The JADE™ and Scoreflex™ PTA balloons are the company's first devices for lower limb and arteriovenous (AV) fistula intervention. The peripheral products are additions to the OrbusNeich portfolio of coronary artery interventional products. OrbusNeich opened i...

Roche’s phase III study of Gazyva meets primary endpoint early

Roche's Gazyva drug demonstrated superior progression-free survival compared to Mabthera/Rituxan in people with previously untreated follicular lymphoma in the phase III Gallium study that met its primary endpoint early.

Palliative, hospice care lacking among dying cancer patients, researcher finds

Medical societies, including the American Society of Clinical Oncology, recommend that patients with advanced cancer receive palliative care soon after diagnosis and receive hospice care for at least the last three days of their life. Yet major gaps...

Thursday 26th May 2016

Fighting diseases affecting the world's most vulnerable population

The University of Geneva (UNIGE) and Geneva University Hospitals (HUG) join forces with close to twenty researchers from partner institutions in Mo¬zambique, Nepal and Peru, as well as with the Graduate Institute and the Università della Svizzera italiana to address the double burden of chronic diseases (NCDs) and neglected tropical diseases (NTDs) affecting the most vulnerable populations in lo...

Slithery new species: Researchers discover Silver Boa in the Bahamas Islands

The team encountered the first individual, a beautiful meter-long silvery female, climbing in a Silver Palm tree near the water's edge on a remote island in the southern Bahamas. As dusk approached, Harvard graduate student and team member Nick Herrmann called out on the radio: "Hey, I've got a snake here." The rest of the team came crashing back to his position, and collectively gasped when they ...

Refusing access to surgery recovery area at a UK hospital unless WHO Safe Surgery Checklist is fully complete

New research showing that refusal to allow surgery teams to take the patient to the recovery room after surgery unless the full WHO Safe Surgery Checklist has been complete is a highly effective way to improve use of the checklist. The study is being presented at Euroanaesthesia 2016 (London, UK, 27-30 May), and is by Dr Rajkumar Rajendram, King's College London, United Kingdom (and formerly of th...

Roche boosted by trial success with blood cancer drug

ZURICH (Reuters) - Roche got a big boost on Friday when a clinical trial testing its new blood cancer drug Gazyva proved successful, lifting prospects for a new medicine that will be pivotal as the Swiss company fights the threat of biosimilar compet...

BRIEF-Active Biotech AB says no dividend would be paid

* In accordance with board of directors' proposal, it was resolved that no dividend would be paid

BRIEF-Hybio Pharmaceutical to pay 2015 dividend on June 2

* Says it to pay cash dividend of 0.25 yuan per 10 shares (before tax) to shareholders of record on June 1 for 2015

UPDATE 2-UK Stocks-Factors to watch on May 27

May 27 (Reuters) - Britain's FTSE 100 index is seen opening up 3 points, or 0.05 percent higher on Friday, according to financial bookmakers, with futures up 0.05 percent ahead of the cash market open. For more on the factors affecting European stock...

Britain's Cameron urges G7 to help reduce antibiotics use

ISE-SHIMA, Japan, May 27 (Reuters) - British Prime Minister David Cameron urged leaders of the G7 industrial powers on Friday to do more to reduce the use of antibiotics and to reward drug companies for developing new medicines to fight drug-resistan...

AstraZeneca potassium drug delayed by manufacturing snag

LONDON, May 27 (Reuters) - AstraZeneca said on Friday U.S. regulators would not approve its new drug for high potassium levels at present due to a manufacturing issue, dealing a blow to a product acquired when it bought ZS Pharma for $2.7 billion las...

BRIEF-Precision System Science to merge with unit Genetein Co., Ltd

* Says it plans to merge with a wholly owned subsidiary, Genetein Co., Ltd

BRIEF-AstraZeneca receives complete response letter from U.S. FDA for sodium zirconium cyclosilicate

* Astrazeneca receives complete response letter from us fda for sodium zirconium cyclosilicate (zs-9) for oral suspension for treatment of hyperkalaemia

BRIEF-Xbrane Biopharma AB Q1 loss before tax widens to SEK 5.5 million

* Q1 total revenue 860,791 Swedish crowns ($104,041) versus 120,272 crowns year ago

BRIEF-AstraZeneca announces positive results in breast cancer trial

* Announced positive results from phase III falcon trial comparing faslodex 500mg (fulvestrant) to arimidex 1mg

BRIEF-MPH Mittelstaendische Pharma Holding Q1 net profit up at 8.69 mln euros

May 27 (Reuters) - MPH Mittelstaendische Pharma Holding AG :

BRIEF-SOBI says enters new credit facility, redeems bond loan

* SOBI enters new credit facility and redeems SEK 800 mln bond loan 2012/2017 prior to final maturity Source text for Eikon: Further company coverage:

DATA: Infographic: Novartis Oncology On The Verge

Like some of the other companies that are behind in the immuno-oncology space, Novartis AG is relying on combination treatments...   

BRIEF-Edan Instruments says 2015 dividend payment date

* Says it will pay a cash dividend of 2.1 yuan (pre-tax) for every 10 shares and use additional paid-in capital to distribute 15 new shares for every 10 shares, to shareholders of record on May 31 for 2015

Roche announces positive results for Gazyva in phase III study

ZURICH (Reuters) - Roche Holding AG said on Friday its drug Gazyva showed superior progression-free survival compared to Mabthera/Rituxan in people with previously untreated follicular lymphoma in the pivotal phase III Gallium study that met is prima...

Normoglycaemia key to improved neurological outcome after paediatric stroke

Achieving normal blood glucose concentrations may be important in preventing poor neurological outcomes in children following acute arterial ischemic stroke, a retrospective review indicates.

BRIEF-Jilin Gpro Titanium cuts share issue size to 1.1 bln yuan

* Says it cuts share issue size to 1.1 billion yuan ($167.73 million) from 4.0 billion yuan previously


The first operator ever to receive the prestigious award Award is for surpassing 100,000 hours, or 50 years, of flying without an accident Highlights company's commitment to safety and security LONDON, May 27, 2016 (GLOBE NEWSWIRE) -- VistaJet, the global leader in business aviation, is pleased to announce it has been honoured at the European Business Aviation Association's (EBAA) S...

BOURBON: 2016 Combined Annual Shareholders' Meeting

PARIS, May 27, 2016 (GLOBE NEWSWIRE) -- The Combined General Meeting of BOURBON shareholders was held on May 26, 2016 in Paris, chaired by Mr. Jacques de Chateauvieux. All resolutions (amended, where required) were approved and notably: - The distribution of a dividend of €1 per share in cash or in shares -    The renewal of Ms. Xiaowei Wang, Mr. Jacques de Chateauvieux and of Mr. Ch...

Quick Search